| 注册
首页|期刊导航|中国伤残医学|观察联合免疫抑制疗法治疗儿童难治型再生障碍性贫血疗效

观察联合免疫抑制疗法治疗儿童难治型再生障碍性贫血疗效

颜丽华

中国伤残医学Issue(8):33-34,2.
中国伤残医学Issue(8):33-34,2.DOI:10.13214/j.cnki.cjotadm.2015.08.022

观察联合免疫抑制疗法治疗儿童难治型再生障碍性贫血疗效

Observation on curative effect of combined immunosuppressive therapy on treating children with refractory aplastic anemia

颜丽华1

作者信息

  • 1. 郑州人民医院颐和医院血液内科,河南郑州 450047
  • 折叠

摘要

Abstract

Objective:To investigate and observe the curative effect of combined immunosuppressive ( CIS) therapy on treating chil-dren with refractory aplastic anemia ( RAA) .Methods:56 cases with RAA were randomly selected, then divided into treatment group and control group.The treatment process of two groups were recorded and compared.Finally, the efficacy was observed.Results: After the treatment, it was markedly indicated that in treatment group, patients with excellent effectiveness were 16 cases ( amounting to 57.1%) in total, those with effectiveness were 11 cases (amounting 39.3%), and those with ineffectiveness were 1 case (amounting to 3.5%), thus the total effective patients were 27 cases ( amounting to 96.4%);while in control group, patients with excellent effectiveness were 9 cases ( amounting to 32.1%) in total, those with effectiveness was 14 case (amounting 50%), and those with ineffectiveness was 5 case (amounting to 17.9%), thus the total effective patients were 23 cases (amounting to 82.1%).Therefore, it was significantly found that the curative effect in treatment group was better than that in control group.Conclusion:Combined immunosuppressive therapy could play a significant efficacy in treating children with refractory aplastic anemia.Moreover, it might be able to protect children by reducing the in-fection probability and avoiding relapse, which should be worth great attention and wide use in clinic.

关键词

难治性再生障碍性贫血/联合免疫抑制疗法

Key words

Refractory aplastic anemia/Combined immunosuppressive therapy

分类

医药卫生

引用本文复制引用

颜丽华..观察联合免疫抑制疗法治疗儿童难治型再生障碍性贫血疗效[J].中国伤残医学,2015,(8):33-34,2.

中国伤残医学

1673-6567

访问量0
|
下载量0
段落导航相关论文